ODDB.org: Open Drug Database

Devatis AG - Temozolomid Devatis 20 mg, Kapseln

Swissmedic Registration	68606	Sequence	02
Product name	Temozolomid Devatis 20 mg	Description	Kapseln
ATC-Classification	L01AX03	ATC-Description	Temozolomide
Introduction of Sequence	17.11.2022

Composition

temozolomidum 20 mg, lactosum 182.2 mg, carboxymethylamylum natricum A corresp. natrium max. 0.5 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Temozolomide	20 mg

BAG: Active Agent	Dose
Temozolomide	20 mg

Inactive agents	Dose	additional_information
(Flavum)
(Nigrum)
Acidum Stearicum
Tartaric Acid
Ammonii Hydroxidum
Carboxymethylamylum Natricum A
E 171		color.
E 172		color.
Gelatina		Kapselhülle
Lacca		Drucktinte
Lactosum	182.2 mg
Pro Capsula
Propylenglycol
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	5	41.80	61.85	A	SL	No
004	20	148.23	177.65	A	SL	No

2025	©ywesee GmbH